All In Biotech

Drug Trial Radar · NCT05034952

A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-dose Study Evaluating the Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty

Last checked: Nov 20, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 303 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

303

Actual

Start

Aug 30, 2021

Primary completion

Dec 5, 2021

Study completion Dec 21, 2021

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Sep 5, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating acute pain after an abdominoplasty.

Conditions

  • Acute Pain

Interventions

  • VX-548Drug

    Tablets for oral administration.

  • HB/APAPDrug

    Capsules for oral administration.

  • Placebo (matched to VX-548)Drug

    Placebo matched to VX-548 for oral administration.

  • Placebo (matched to HB/APAP)Drug

    Placebo matched to HB/APAP for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time-weighted Sum of the Pain Intensity Difference (SPID) as Recorded on a Numeric Pain Rating Scale (NPRS) at Rest 0 to 48 Hours (SPIDr0-48) After the First Dose of Study DrugTime frame: 0 to 48 Hours After First Dose of Study Drug

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Research Center

    Phoenix, Arizona

  • Lotus Clinical Research

    Pasadena, California

  • Chesapeake Research Group

    Pasadena, Maryland

  • Midwest Clinical Research Center

    Dayton, Ohio

  • First Surgical Hospital

    Bellaire, Texas

  • Endeavor Clinical Trials

    San Antonio, Texas

  • JBR Clinical Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.